NITD008 is primarily researched for its potential as an antiviral agent, particularly in the treatment of dengue virus infections. It functions by inhibiting the RNA-dependent RNA polymerase of the virus, which is crucial for viral replication. This makes it a promising candidate for developing effective treatments against dengue, a disease with significant global health impact. Additionally, its mechanism of action is being studied for potential application against other flaviviruses, expanding its therapeutic scope. Research is ongoing to optimize its efficacy, safety, and pharmacokinetic properties for clinical use.